Fuhrman Grade Provides Higher Prognostic Accuracy Than Nucleolar Grade for Papillary Renal Cell Carcinoma

Journal of Urology

Volumn 183, Issue 6, 2010, Pages 2143-2147

  Klatte, Tobias ^a   Anterasian, Christine ^a   Said, Jonathan W ^a   de Martino, Michela ^a   Kabbinavar, Fairooz F ^a   Belldegrun, Arie S ^a   Pantuck, Allan J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

carcinoma; kidney; kidney neoplasms; mortality; prognosis; renal cell

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FEMALE; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PAPILLARY CARCINOMA; PARTIAL NEPHRECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

CARCINOMA, RENAL CELL; CELL NUCLEOLUS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 77951878655     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.02.023     Document Type: Article

References (29)

1. Srigley J.R., Hutter R.V.P., Gelb A.B., et al. Current prognostic factors-renal cell carcinoma-Workgroup No. 4. Cancer 80 (1997) 994
2. Gelb A.B. Renal cell carcinoma-current prognostic factors. Cancer 80 (1997) 981
3. Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 22 suppl. (2009) S24
4. Tickoo S.K., and Gopalan A. Pathologic features of renal cortical tumors. Urol Clin North Am 35 (2008) 551
5. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655
6. Goldstein N.S. The current state of renal cell carcinoma grading. Cancer 80 (1997) 977
7. Cheville J.C., Lohse C.M., Zincke H., et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27 (2003) 612
8. Patard J.J., Leray E., Rioux-Leclercq N., et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23 (2005) 2763
9. Ficarra V., Martignoni G., Maffei N., et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103 (2005) 68
10. Kovacs G., Akhtar M., Beckwith B.J., et al. The Heidelberg classification of renal cell tumours. J Pathol 183 (1997) 131
11. Eble J.N., Togashi K., and Pisani P. Tumours of the kidney. In: Eble J.N., Sauter G., Epstein J.I., et al. (Eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon 9-87 chapt 1
12. Tsui K.H., Shvarts O., Smith R.B., et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163 (2000) 1090
13. Sika-Paotonu D., Bethwaite P.B., McCredie M.R., et al. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 30 (2006) 1091
14. Delahunt B., Sika-Paotonu D., Bethwaite P.B., et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 31 (2007) 957
15. Delahunt B., Eble J.N., McCredie M.R., et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32 (2001) 590
16. Klatte T., Pantuck A.J., Said J.W., et al. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res 15 (2009) 1162
17. Pignot G., Elie C., Conquy S., et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 69 (2007) 230
18. Delahunt B., and Eble J.N. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10 (1997) 537
19. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649
20. Leroy X., Zini L., Buob D., et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med 131 (2007) 102
21. Cangiano T., Liao J., Naitoh J., et al. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol 17 (1999) 523
22. Méjean A., Hopirtean V., Bazin J.P., et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 170 (2003) 764
23. Gontero P., Ceratti G., Guglielmetti S., et al. Prognostic factors in a prospective series of papillary renal cell carcinoma. BJU Int 102 (2008) 697
24. Waldert M., Haitel A., Marberger M., et al. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. BJU Int 102 (2008) 1381
25. Lohse C.M., Blute M.L., Zincke H., et al. Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol 118 (2002) 877
26. Novara G., Martignoni G., Artibani W., et al. Grading systems in renal cell carcinoma. J Urol 177 (2007) 430
27. Lam J.S., Klatte T., Kim H.L., et al. Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol 65 (2008) 235
28. Visapää H., Bui M., Huang Y., et al. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 61 (2003) 845
29. Klatte T., Seligson D.B., Larochelle J., et al. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev 18 (2009) 894